Expertise in
5
conditions

Dr. Michael J. Reardon

Addiction Medicine
41 Dunlop Rd, 
Huntington, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
41 Dunlop Rd, 
Huntington, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Reardon is an Addiction Medicine provider in Huntington, New York. Dr. Reardon is highly rated in 5 conditions, according to our data. His top areas of expertise are End-Stage Renal Disease (ESRD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 502 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Addiction Medicine
Licenses
Addiction Medicine in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

41 Dunlop Rd, Huntington, NY 11743

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

VANTAGE Clinical Trial Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
VANTAGE Clinical Trial Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
Enrollment Status: Recruiting
Publish Date: April 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Evaluation of the Portico™ NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Device
Study Phase: Not Applicable
Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease
Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
REPRISE III: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Randomized Clinical Evaluation
REPRISE III: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Randomized Clinical Evaluation
Enrollment Status: Terminated
Publish Date: December 17, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

502 Total Publications

Transcatheter edge-to-edge repair for the management of secondary mitral regurgitation - CRT 2025 Beyond the Guidelines.
Transcatheter edge-to-edge repair for the management of secondary mitral regurgitation - CRT 2025 Beyond the Guidelines.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: August 04, 2025
Similar Doctors
Expertise in
1
conditions
Dr. Hayman Rambaran
Addiction Medicine
Expertise in
1
conditions
Dr. Hayman Rambaran
Addiction Medicine

Bergen County Improvement Authority

230 E Ridgewood Ave, 
Paramus, NJ 
 (35.6 miles away)
201-967-4000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Hayman Rambaran is an Addiction Medicine provider in Paramus, New Jersey. Dr. Rambaran is highly rated in 1 condition, according to our data. His top area of expertise is Opioid Use Disorder. Dr. Rambaran is currently accepting new patients.

Expertise in
1
conditions
Dr. Ajay Manhapra
Addiction Medicine
Expertise in
1
conditions
Dr. Ajay Manhapra
Addiction Medicine
950 Campbell Ave, 
West Haven, CT 
 (36.6 miles away)
203-932-5711
Languages Spoken:
English
See accepted insurances

Ajay Manhapra is an Addiction Medicine provider in West Haven, Connecticut. Dr. Manhapra is highly rated in 1 condition, according to our data. His top areas of expertise are Opioid Use Disorder and Traumatic Brain Injury.

Expertise in
1
conditions
Dr. Julia M. Shi
Addiction Medicine
Expertise in
1
conditions
Dr. Julia M. Shi
Addiction Medicine

Apt Foundation, Inc

1 Long Wharf Dr, 
New Haven, CT 
 (37.8 miles away)
203-781-4640
Languages Spoken:
English
See accepted insurances

Julia Shi is an Addiction Medicine provider in New Haven, Connecticut. Dr. Shi is highly rated in 1 condition, according to our data. Her top area of expertise is Opioid Use Disorder.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reardon's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile